Literature DB >> 28179108

Revisiting Metchnikoff: Age-related alterations in microbiota-gut-brain axis in the mouse.

Karen A Scott1, Masayuki Ida2, Veronica L Peterson3, Jack A Prenderville1, Gerard M Moloney4, Takayuki Izumo2, Kiera Murphy5, Amy Murphy5, R Paul Ross6, Catherine Stanton5, Timothy G Dinan7, John F Cryan8.   

Abstract

Over the last decade, there has been increased interest in the role of the gut microbiome in health including brain health. This is by no means a new theory; Elie Metchnikoff proposed over a century ago that targeting the gut by consuming lactic acid bacteria such as those in yogurt, could improve or delay the onset of cognitive decline associated with ageing. However, there is limited information characterising the relationship between the behavioural and physiological sequelae of ageing and alterations in the gut microbiome. To this end, we assessed the behavioural, physiological and caecal microbiota profile of aged male mice. Older mice (20-21months old) exhibited deficits in spatial memory and increases in anxiety-like behaviours compared to younger mice (2-3months old). They also exhibited increased gut permeability, which was directly correlated with elevations in peripheral pro-inflammatory cytokines. Furthermore, stress exacerbated the gut permeability of aged mice. Examination of the caecal microbiota revealed significant increases in phylum TM7, family Porphyromonadaceae and genus Odoribacter of aged mice. This represents a shift of aged microbiota towards a profile previously associated with inflammatory disease, particularly gastrointestinal and liver disorders. Furthermore, Porphyromonadaceae, which has also been associated with cognitive decline and affective disorders, was directly correlated with anxiety-like behaviour in aged mice. These changes suggest that changes in the gut microbiota and associated increases in gut permeability and peripheral inflammation may be important mediators of the impairments in behavioural, affective and cognitive functions seen in ageing.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ageing; Anxiety; Behaviour; Cognitive impairment; Gut permeability; Inflammation; Microbiota; Microbiota-gut-brain axis

Mesh:

Substances:

Year:  2017        PMID: 28179108     DOI: 10.1016/j.bbi.2017.02.004

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  59 in total

1.  Is the fountain of youth in the gut microbiome?

Authors:  John F Cryan; Marcus Boehme; Timothy G Dinan
Journal:  J Physiol       Date:  2019-04-02       Impact factor: 5.182

2.  Suppression of the gut microbiome ameliorates age-related arterial dysfunction and oxidative stress in mice.

Authors:  Vienna E Brunt; Rachel A Gioscia-Ryan; James J Richey; Melanie C Zigler; Lauren M Cuevas; Antonio Gonzalez; Yoshiki Vázquez-Baeza; Micah L Battson; Andrew T Smithson; Andrew D Gilley; Gail Ackermann; Andrew P Neilson; Tiffany Weir; Kevin P Davy; Rob Knight; Douglas R Seals
Journal:  J Physiol       Date:  2019-02-27       Impact factor: 5.182

3.  Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.

Authors:  Marcel van de Wouw; Marcus Boehme; Joshua M Lyte; Niamh Wiley; Conall Strain; Orla O'Sullivan; Gerard Clarke; Catherine Stanton; Timothy G Dinan; John F Cryan
Journal:  J Physiol       Date:  2018-08-28       Impact factor: 5.182

4.  Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function.

Authors:  Sofia Cussotto; Conall R Strain; Fiona Fouhy; Ronan G Strain; Veronica L Peterson; Gerard Clarke; Catherine Stanton; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2018-08-28       Impact factor: 4.530

Review 5.  Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder.

Authors:  Thomaz F S Bastiaanssen; Sofia Cussotto; Marcus J Claesson; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Harv Rev Psychiatry       Date:  2020 Jan/Feb       Impact factor: 3.732

Review 6.  The role of the gut microbiome in mediating neurotoxic outcomes to PCB exposure.

Authors:  Kavi M Rude; Ciara E Keogh; Mélanie G Gareau
Journal:  Neurotoxicology       Date:  2019-08-24       Impact factor: 4.294

7.  Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis.

Authors:  Shokouh Ahmadi; Atefeh Razazan; Ravinder Nagpal; Shalini Jain; Bo Wang; Sidharth P Mishra; Shaohua Wang; Jamie Justice; Jingzhong Ding; Donald A McClain; Stephen B Kritchevsky; Dalane Kitzman; Hariom Yadav
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-06-18       Impact factor: 6.053

8.  A human-origin probiotic cocktail ameliorates aging-related leaky gut and inflammation via modulating the microbiota/taurine/tight junction axis.

Authors:  Shokouh Ahmadi; Shaohua Wang; Ravinder Nagpal; Bo Wang; Shalini Jain; Atefeh Razazan; Sidharth P Mishra; Xuewei Zhu; Zhan Wang; Kylie Kavanagh; Hariom Yadav
Journal:  JCI Insight       Date:  2020-05-07

9.  Influenza Virus Infection Impairs the Gut's Barrier Properties and Favors Secondary Enteric Bacterial Infection through Reduced Production of Short-Chain Fatty Acids.

Authors:  Valentin Sencio; Alexandre Gallerand; Marina Gomes Machado; Lucie Deruyter; Séverine Heumel; Daphnée Soulard; Johanna Barthelemy; Céline Cuinat; Angelica T Vieira; Adeline Barthelemy; Luciana P Tavares; Rodolphe Guinamard; Stoyan Ivanov; Corinne Grangette; Mauro M Teixeira; Benoit Foligné; Isabelle Wolowczuk; Ronan Le Goffic; Muriel Thomas; François Trottein
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

10.  Examining the Role of Microbiota in Emotional Behavior: Antibiotic Treatment Exacerbates Anxiety in High Anxiety-Prone Male Rats.

Authors:  M E Glover; J L Cohen; J R Singer; M N Sabbagh; J R Rainville; M T Hyland; C D Morrow; C T Weaver; G E Hodes; Ilan A Kerman; S M Clinton
Journal:  Neuroscience       Date:  2021-02-01       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.